Logo
x

Search

Subscribe Now

the US

Disease of the Month: Age-Related Macular Degeneration

Disease of the Month: Age-Related Macular Degeneration

  • February 9, 2023
The US FDA Rejects Gilead's Filgotinib Due to Toxicity Issues

The US FDA Rejects Gilead's Filgotinib Due to Toxicity Issues

  • August 19, 2020
CytoDyn Signs an Agreement with American Regent for Leronlimab to Treat COVID-19 Patients in the US

CytoDyn Signs an Agreement with American Regent for Leronlimab to Treat COVID-19 Patients in the US

  • July 6, 2020
Celltrion Reports Results of Truxima (biosimilar- rituximab) in P-III Study for Advanced Follicular Lymphoma in the US

Celltrion Reports Results of Truxima (biosimilar- rituximab) in P-III Study for Advanced Follicular Lymphoma in the US

  • December 12, 2019
Mylan and Biocon Launch Ogivri (biosimilar- trastuzumab) in the US

Mylan and Biocon Launch Ogivri (biosimilar- trastuzumab) in the US

  • December 2, 2019
Pfizer to Launch its Zirabev (biosimilar- bevacizumab) in the US by the year end 2019

Pfizer to Launch its Zirabev (biosimilar- bevacizumab) in the US by the year end 2019

  • October 1, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.